JorgeASantanaMDFIDSA(He/Him)

[Pronunciation: Jorge L Santana MD]

Infectious Disease • Manati, PR

HIV/AIDS Medicine

Professor Medicine & Infectious Disease Univ. PR School of Medicine

Join to view full profile

Dr. Santana is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Santana's full profile

Already have an account?

Office
Manati Medical Center Dr Otero Lopez
Manati, PR 00674
Phone+1 787-398-7955

Education & Training

VA Caribbean Healthcare SystemFellowship, Infectious Disease, 1985 - 1988
Yale-New Haven Medical Center (Waterbury)Residency, Internal Medicine, 1983 - 1985
Yale-New Haven Medical CenterInternship, Internal Medicine, 1982 - 1983
Universidad Central del Caribe School of MedicineClass of 1982

Certifications & Licensure

PR State Medical License 1987 - 2025

Publications & Presentations

PubMed

99 citations
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-in...
Jean-Michel Molina, Kathleen Squires, Paul E. Sax, P. Cahn, Johan Lombaard
The Lancet. HIV. 2018-05-01
37 citations
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.
Sunil S Solomon, Sandra Wagner-Cardoso, Laura Smeaton, Leonard A Sowah, Chanelle Wimbish
The Lancet. Gastroenterology & Hepatology. 2022-04-01
42 citations
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).
Roy M. Gulick, Timothy J. Wilkin, Ying Q. Chen, Raphael J. Landovitz, K. Rivet Amico
The Journal of Infectious Diseases. 2016-11-02